These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35911924)
1. Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis. Si JH; Ma N; Gao F; Mo DP; Luo G; Miao ZR Front Neurol; 2022; 13():854226. PubMed ID: 35911924 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial. Jia B; Zhang X; Ma N; Mo D; Gao F; Sun X; Song L; Liu L; Deng Y; Xu X; Zhang Y; Liu Z; Guan S; Zhang F; Li B; Zheng H; Liu X; Liu Y; Chen K; Shuai J; Wan J; Wang J; Shi X; Li T; Chang B; Liebeskind DS; Yu W; Miao Z; JAMA Neurol; 2022 Feb; 79(2):176-184. PubMed ID: 34982098 [TBL] [Abstract][Full Text] [Related]
3. Validation and comparison of drug eluting stent to bare metal stent for restenosis rates following vertebral artery ostium stenting: A single-center real-world study. Li L; Wang X; Yang B; Wang Y; Gao P; Chen Y; Zhu F; Ma Y; Chi H; Zhang X; Bai X; Feng Y; Dmytriw AA; Hong T; Hua Y; Jiao L; Ling F Interv Neuroradiol; 2020 Oct; 26(5):629-636. PubMed ID: 32799746 [TBL] [Abstract][Full Text] [Related]
4. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881 [TBL] [Abstract][Full Text] [Related]
5. Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting. Maciejewski DR; Pieniazek P; Tekieli L; Paluszek P; Przewlocki T; Tomaszewski T; Machnik R; Trystula M; Legutko J; Kablak-Ziembicka A Postepy Kardiol Interwencyjnej; 2019; 15(3):328-337. PubMed ID: 31592257 [TBL] [Abstract][Full Text] [Related]
6. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis. Song L; Li J; Gu Y; Yu H; Chen B; Guo L; Zhang J J Endovasc Ther; 2012 Apr; 19(2):231-8. PubMed ID: 22545889 [TBL] [Abstract][Full Text] [Related]
7. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. Zaidat OO; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Megerian JT; Lesko J; Pitzer P; Ramos J; Castonguay AC; Barnwell S; Smith WS; Gress DR; JAMA; 2015 Mar 24-31; 313(12):1240-8. PubMed ID: 25803346 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel Coated Balloon vs. Bare Metal Stent for Endovascular Treatment of Symptomatic Vertebral Artery Origin Stenosis Patients: Protocol for a Randomized Controlled Trial. Wang Y; Ma Y; Gao P; Chen Y; Yang B; Feng Y; Jiao L Front Neurol; 2020; 11():579238. PubMed ID: 33584491 [No Abstract] [Full Text] [Related]
9. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis. Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435 [TBL] [Abstract][Full Text] [Related]
10. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies. Langwieser N; Buyer D; Schuster T; Haller B; Laugwitz KL; Ibrahim T J Endovasc Ther; 2014 Oct; 21(5):683-92. PubMed ID: 25290797 [TBL] [Abstract][Full Text] [Related]
11. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials. Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C; Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868 [TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C; J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457 [TBL] [Abstract][Full Text] [Related]
13. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent. Ge H; Zhang Q; Zhou W; He Q; Han ZH; He B J Zhejiang Univ Sci B; 2010 Aug; 11(8):553-60. PubMed ID: 20669344 [TBL] [Abstract][Full Text] [Related]
15. The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry. Abizaid A; Costa JR; Banning A; Bartorelli AL; Dzavik V; Ellis S; Gao R; Holmes DR; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Orlick A; Spaulding C; Worthley S; Urban PM; JACC Cardiovasc Interv; 2012 Jan; 5(1):64-71. PubMed ID: 22230152 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Rapamycin-Eluting Vertebral Stents in Patients With Symptomatic Extracranial Vertebral Artery Stenosis. Ma G; Song L; Ma N; Raynald ; Shuai J; Wu W; Wan J; Zhao Z; Li G; Yin S; Ding S; Li J; Jia B; Tong X; Mo D; Gao F; Sun X; Deng Y; Huo X; Li W; Chen K; Miao Z Front Neurol; 2021; 12():649426. PubMed ID: 34899552 [No Abstract] [Full Text] [Related]
17. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508 [TBL] [Abstract][Full Text] [Related]
18. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial. Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449 [TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis. Singh IM; Filby SJ; El Sakr F; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH Catheter Cardiovasc Interv; 2010 Aug; 76(2):257-62. PubMed ID: 20665874 [TBL] [Abstract][Full Text] [Related]